Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer

Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer

BackgroundProteinuria is the most frequent adverse event of lenvatinib use. However, the association between lenvatinib-induced proteinuria and renal dysfunction remains unclear.MethodsWe retrospectively reviewed medical records of patients with thyroid cancer without proteinuria treated with lenvat...

Full description

Bibliographic Details
Main Authors: Yuma Shibutani, Shinya Suzuki, Atsunobu Sagara, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
thyroid cancer
lenvatinib
proteinuria
renal dysfunction
VEGF inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1154771/full

Similar Items

Similar Items